News and Resources

News and resources

A new vaccine against typhoid rolls out in a flood-devastated province of Pakistan

04 Nov 2022

Armed with vials of Typhoid Conjugate Vaccine, health workers in Balochistan are doing what they can to protect children threatened by a pincer movement of global crises: antimicrobial resistance on the one hand and climate change on the other.

IFFIm returns to market with US$ 500 million 3-year bond

25 Oct 2022

The International Finance Facility for Immunisation Company (IFFIm) today priced a US$ 500 million, 3-year fixed rate bond to provide Gavi, the Vaccine Alliance, with immediately available funding to support routine immunisation in lower-income countries, reaching nearly half the world’s children.

Gavi Annual Progress Report: 2021 was “defining” for IFFIm

21 Oct 2022

From its founding in 2000 to the end of 2021, Gavi has helped to immunise a whole generation – over 981 million children – and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries by the end of 2021. These are a few of the results published in Gavi’s 2021 Annual Progress Report.

How the World Bank built trust in vaccine bonds

21 Oct 2022

Interview with Doris Herrera-Pol and Heike Reichelt.

A mountain to climb: often – too often – the “last mile” is a health worker’s extra mile

04 Oct 2022

Michelline Uwimana treks through the mountainous terrain of rural Uganda come rain or shine. The walk is gruelling, but the alternative – communities going without vital healthcare – would be worse.

Local solutions to local problems: Reaching zero-dose children in Chad’s nomadic communities

06 Sep 2022

An innovative approach that combines children and animal vaccinations is helping to boost coverage amongst zero-dose children in Chad’s nomadic communities.

Bangladesh’s success in dealing with COVID-19

01 Sep 2022

A quick response, early drive for vaccines, proper campaign management and mass participation have helped Bangladesh fully vaccinate more than 70% of its population against COVID-19.